Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRRO
#3647
Korro Bio, Inc. - Common Stock
13.5
0
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
0.00%
Monthly Change
+14.12%
6 month change
+50.50%
Year Change
-65.30%
Previous Close
13.5
0
Open
13.5
0
Low
13.3
7
High
13.5
3
Volume
28
Markets
US Stock Market
Healthcare
Biotechnology
KRRO
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
34.18 M
34.98 M
35.29 M
8.02 M
9.39 M
14.42 M
14.42 M
Valuation ratios
Enterprise value
—
—
—
228.05 M
301.79 M
93.7 M
153.2 M
Price to earnings ratio
—
—
—
-0.93
-4.06
-0.64
-1.28
Price to sales ratio
—
—
—
—
149.54
11.77
36.43
Price to cash flow ratio
—
—
—
-1.12
5.65
-0.96
-2.08
Price to book ratio
—
—
—
0.44
0.49
1.46
0.39
Enterprise value to EBITDA ratio
—
—
—
-2.82
-3.35
-0.79
-1.34
Profitability ratios
Return on assets %
-0.1
-0.46
-0.67
-0.37
-0.37
-1.03
-0.11
Return on equity %
-0.14
-0.65
-1.18
-0.48
-0.52
-2.28
-0.16
Return on invested capital %
-211.02
-626.33
-671.01
-664.2
-487.96
-1 449.69
-163.88
Gross margin %
100
100
—
—
100
100
—
Operating margin %
-74.49
-597.32
—
—
-4 047.12
-1 906.37
—
EBITDA margin %
-71.39
-577.59
—
—
-3 968.6
-1 847.06
—
Net margin %
-71.68
-601.98
—
—
-3 680.36
-1 834.48
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.45
11.79
4.16
8.87
8.79
6.9
8.13
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.15
0.06
0
0
0.01
0.04
0
Solvency ratios
Debt to assets ratio
0.06
0.08
0.12
—
—
—
—
Debt to equity ratio
0.08
0.11
0.2
—
—
—
—
Long term debt to total assets ratio
0.06
0.08
0.03
—
—
—
—
Long term debt to total equity ratio
0.08
0.11
0.06
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
-44
-6.73
-8.36
-7.15
EBIT per share
—
—
—
-55.28
-10.3
-12.97
-12.07
EBITDA per share
—
—
—
-52.95
-10.1
-12.57
-11.73
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
—
108.64
14.14
8
9.83
Net current asset value per share
—
—
—
112.94
14.74
8.77
10.36
Tangible book value per share
—
—
—
111.1
17.98
5.47
10.31
Working capital per share
—
—
—
100.2
13.07
7.5
9.09
Book value per share
—
—
—
111.1
17.98
5.47
10.31
News
Korro Bio, Inc. (KRRO) Upgraded to Buy: What Does It Mean for the Stock?
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock?
Korro Bio: RNA Editor Plots Way Back After AATD Study Fail - I'm Holding (NASDAQ:KRRO)
What Makes Korro Bio, Inc. (KRRO) a New Buy Stock
Thursday’s insider buys and sells: AdaptHealth leads activity
Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot
Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million
Korro Bio investor buys $2.3 million in KRRO stock
Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates
United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?